Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
(NYSE: LCTX) Delayed: 1.08 -0.02 (1.82%)
Previous Close $1.10    52 Week High
Open $1.09    52 Week Low
Day High $1.11    P/E N/A 
Day Low $1.08    EPS
Volume 535,726       

(NYSE: LCTX) Delayed: 1.08 -0.02 (1.82%)
Previous Close $1.10    52 Week High
Open $1.09    52 Week Low
Day High $1.11    P/E N/A 
Day Low $1.08    EPS
Volume 535,726